ArticleAlzheimer's research & therapy2021

Correction to: Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive decline.

Julia Stockmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.